Loading...
Effective utilization of oral hypoglycemic agents to achieve individualized HbA1c targets in patients with type 2 diabetes mellitus
Berlanga, J.
Berlanga, J.
Publication Date
2016-09
End of Embargo
Supervisor
Rights
© 2016 The Author(s). This is an Open Access article distributed under the Creative Commons CC-BY-NC license
(http://creativecommons.org/licenses/by-nc/4.0/)
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2016
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Type 2 diabetes is a progressive condition that may require the combination of three oral treatments to achieve optimal glycemic management to prevent microvascular and macrovascular complications whilst minimizing the risk of acute complications and side effects or adverse reactions to treatments. With the widening availability of treatment options and increasing importance of individualized treatment pathways, including personalized HbA1c targets, this article will explore the mode of action of currently available oral treatments, factors to consider when individualizing HbA1c targets, the relevance of estimated glomerular filtration rate assessment, and the importance of reviewing the clinical impact of all treatment decisions.
Version
Published version
Citation
Bannister M and Berlanga J (2016) Effective utilization of oral hypoglycemic agents to achieve individualized HbA1c targets in patients with type 2 diabetes mellitus. Diabetes Therapy.
7(3): 387-399.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article